Reply: Post-COVID-19 Myoclonus-Ataxia Syndrome-Is there Really a Need for Intravenous Immunoglobulin Treatment in all Cases?
作者信息
Godani Massimiliano, Beronio Alessandro, Lanza Giuseppe
机构信息
Department of Neurology Sant'Andrea Civic Hospital, ASL 5 Spezzino La Spezia Italy.
Department of Surgery and Medical-Surgical Specialties University of Catania Catania Italy.
出版信息
Mov Disord Clin Pract. 2023 Mar 25;10(4):726-727. doi: 10.1002/mdc3.13693. eCollection 2023 Apr.
Abstract
摘要
相似文献
1
Reply: Post-COVID-19 Myoclonus-Ataxia Syndrome-Is there Really a Need for Intravenous Immunoglobulin Treatment in all Cases?回复：新冠后肌阵挛-共济失调综合征——所有病例真的都需要静脉注射免疫球蛋白治疗吗？
Mov Disord Clin Pract. 2023 Mar 25;10(4):726-727. doi: 10.1002/mdc3.13693. eCollection 2023 Apr.
2
Two COVID-19-related video-accompanied cases of severe ataxia-myoclonus syndrome.两例与 COVID-19 相关的伴有视频的严重共济失调-肌阵挛综合征病例。
Neurol Neurochir Pol. 2021;55(3):310-313. doi: 10.5603/PJNNS.a2021.0036. Epub 2021 Jun 7.
3
Post-COVID-19 Myoclonus-Ataxia Syndrome-Is there Really a Need for Intravenous Immunoglobulin Treatment in all Cases?新冠后肌阵挛-共济失调综合征——所有病例真的都需要静脉注射免疫球蛋白治疗吗？
Mov Disord Clin Pract. 2023 Mar 25;10(4):724-725. doi: 10.1002/mdc3.13695. eCollection 2023 Apr.
4
Opsoclonus Myoclonus Ataxia Syndrome Due to SARS-CoV-2.由严重急性呼吸综合征冠状病毒2（SARS-CoV-2）引起的眼阵挛-肌阵挛-共济失调综合征
Neuroophthalmology. 2022 Dec 15;47(1):1-6. doi: 10.1080/01658107.2022.2128378. eCollection 2023.
5
Post-COVID-19 Myoclonus-Ataxia Syndrome Responsive to Intravenous Immunoglobulins.对静脉注射免疫球蛋白有反应的新冠后肌阵挛-共济失调综合征
Mov Disord Clin Pract. 2022 Sep 11;9(Suppl 2):S6-S8. doi: 10.1002/mdc3.13534. eCollection 2022 Sep.
6
Retrospective analysis of COVID-19 patients with Guillain-Barre, Miller-Fisher, and opsoclonus-myoclonus-ataxia syndromes-a case series.回顾性分析吉兰-巴雷、米勒-费舍尔和眼阵挛-肌阵挛-共济失调综合征合并 COVID-19 的患者：病例系列研究。
Wien Med Wochenschr. 2024 Feb;174(1-2):30-34. doi: 10.1007/s10354-023-01018-4. Epub 2023 Jul 31.
7
Opsoclonus-Myoclonus-Ataxia Syndrome (OMAS) Associated with SARS-CoV-2 Infection: Post-Infectious Neurological Complication with Benign Prognosis.Opsoclonus-Myoclonus-Ataxia 综合征（OMAS）与 SARS-CoV-2 感染相关：具有良性预后的感染后神经系统并发症。
Tremor Other Hyperkinet Mov (N Y). 2021 Feb 10;11:7. doi: 10.5334/tohm.580.
8
Acute cerebellar ataxia and myoclonus with or without opsoclonus: a para-infectious syndrome associated with COVID-19.急性小脑共济失调和肌阵挛伴或不伴眼球震颤：与 COVID-19 相关的拟传染性综合征。
Eur J Neurol. 2021 Oct;28(10):3533-3536. doi: 10.1111/ene.14726.
9
Ataxia-Myoclonus Syndrome in Patients with SARS-CoV-2 Infection.新型冠状病毒肺炎患者的共济失调-肌阵挛综合征
Can J Neurol Sci. 2022 Nov;49(6):824-825. doi: 10.1017/cjn.2021.234. Epub 2021 Oct 14.
10
Myoclonus status revealing COVID 19 infection.肌阵挛状态揭示 COVID-19 感染。
Seizure. 2023 Jan;104:12-14. doi: 10.1016/j.seizure.2022.11.010. Epub 2022 Nov 22.
本文引用的文献
1
Post-COVID-19 Myoclonus-Ataxia Syndrome-Is there Really a Need for Intravenous Immunoglobulin Treatment in all Cases?新冠后肌阵挛-共济失调综合征——所有病例真的都需要静脉注射免疫球蛋白治疗吗？
Mov Disord Clin Pract. 2023 Mar 25;10(4):724-725. doi: 10.1002/mdc3.13695. eCollection 2023 Apr.
2
Post-COVID-19 Myoclonus-Ataxia Syndrome Responsive to Intravenous Immunoglobulins.对静脉注射免疫球蛋白有反应的新冠后肌阵挛-共济失调综合征
Mov Disord Clin Pract. 2022 Sep 11;9(Suppl 2):S6-S8. doi: 10.1002/mdc3.13534. eCollection 2022 Sep.
3
Relationship between COVID-19 and movement disorders: A narrative review.新型冠状病毒肺炎与运动障碍的关系：一项叙述性综述。
Eur J Neurol. 2022 Apr;29(4):1243-1253. doi: 10.1111/ene.15217. Epub 2021 Dec 31.
4
Two COVID-19-related video-accompanied cases of severe ataxia-myoclonus syndrome.两例与 COVID-19 相关的伴有视频的严重共济失调-肌阵挛综合征病例。
Neurol Neurochir Pol. 2021;55(3):310-313. doi: 10.5603/PJNNS.a2021.0036. Epub 2021 Jun 7.
5
Intravenous immunoglobulin therapy in COVID-19-related encephalopathy.COVID-19 相关性脑病的静脉注射免疫球蛋白治疗。
J Neurol. 2021 Aug;268(8):2671-2675. doi: 10.1007/s00415-020-10248-0. Epub 2020 Oct 8.
Zotero 插件